SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-08-033060
Filing Date
2008-05-27
Accepted
2008-05-27 16:13:03
Documents
1
Period of Report
2008-05-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4013
  Complete submission text file 0001209191-08-033060.txt   5843
Mailing Address 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 125 SIDNEY STREET CAMBRIDGE MA 02139 617-299-2900
Altus Pharmaceuticals Inc. (Issuer) CIK: 0001340744 (see all company filings)

IRS No.: 043573277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1

Mailing Address C/O ALTUS PHARMACEUTICALS INC. 125 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 617-299-2900
Lieber Jonathan I (Reporting) CIK: 0001350090 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51711 | Film No.: 08860916